Role, Cost, and Availably of Urinary pH Monitoring for Kidney Stone Disease-A Systematic Review of the Literature.


Journal

Current urology reports
ISSN: 1534-6285
Titre abrégé: Curr Urol Rep
Pays: United States
ID NLM: 100900943

Informations de publication

Date de publication:
Aug 2023
Historique:
accepted: 09 05 2023
medline: 7 8 2023
pubmed: 14 6 2023
entrez: 14 6 2023
Statut: ppublish

Résumé

Urinary pH is an important factor related to renal stone disease, and it plays an essential role in stone prevention. Monitoring of urinary pH by patients at home provides information that can help to assess the treatment needed by each patient. We conducted a systematic review is to assess the available evidence concerning urinary pH monitoring methods along with their accuracy, cost, and usefulness by patients with urolithiasis. A total of 9 articles were included (1886 urinary pH measurements). They reported information about urinary dipsticks, portable electronic pH meters and electronic strip readers, amongst other methods. Accuracy was compared with a laboratory pH meter (gold standard). Urinary dipsticks were found to be not accurate enough to guide clinical decision making and portable electronic pH meters showed promising results. Urinary dipsticks are neither precise nor accurate enough. Portable electronic pH meters seem to be more accurate, easy to use, and cost-effective. They are a reliable source for patients to use at home in order to prevent future episodes of nephrolithiasis.

Identifiants

pubmed: 37314611
doi: 10.1007/s11934-023-01166-5
pii: 10.1007/s11934-023-01166-5
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-388

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

Isabel Sanz-Gómez (I)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain. isa.sanzgomez@gmail.com.

Oriol Angerri (O)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.

Michael Baboudjian (M)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Department of Urology, North Hospital, APHM, Marseille, France.

Andrés Kanashiro (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.

Sílvia Gracia (S)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.

Félix Millán (F)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.

Francisco Sánchez-Martín (F)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.

Bhaskar Somani (B)

Department of Urology, University Hospital Southampton, Southampton, UK.

Juan Antonio Galan-Llopis (JA)

Department of Urology, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.

Yazeed Barghouthy (Y)

Department of Urology, CH Valenciennes, Valenciennes, France.

Esteban Emiliani (E)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH